Search research articles
Contact Us
Filters
Showing results (91-100 of 247) with videos related to
Page
of 25
Sort By:
Proceedings of the Royal Society of London. Series B, Biological Sciences
|
February 17, 1970
The tiered retina of Dytiscus: a new type of compound eye
G A Horridge, B Walcott, A C Ioannides
Xenobiotica; the Fate of Foreign Compounds in Biological Systems
|
March 17, 1999
Structural and functional integrity of precision-cut liver slices in xenobiotic metabolism: a comparison of the dynamic organ and multiwell plate culture procedures
E Hashemi, M Dobrota, C Till, et al.
Chemico-Biological Interactions
|
January 1, 1990
Hyperketonaemia markedly modulates the metabolic activation of chemical carcinogens
C R Barnett, P R Flatt, C Ioannides
Mutation Research
|
March 21, 1998
Further evaluation of COMPACT, the molecular orbital approach for the prospective safety evaluation of chemicals
D F Lewis, C Ioannides, D V Parke
Toxicology Letters
|
April 1, 1983
Species variation in the metabolic activation of paracetamol to toxic intermediates: role of cytochromes p-450 and p-448
C Ioannides, C M Steele, D V Parke
Human & Experimental Toxicology
|
November 20, 1998
A combined COMPACT and HazardExpert study of 40 chemicals for which information on mutagenicity and carcinogenicity is known, including the results of human epidemiological studies
D F Lewis, C Ioannides, D V Parke
International Journal of Oncology
|
May 17, 2011
Dissimilar tcr v-Beta frequencies in til from different sites of the same tumor
B Fisk, C Flytzanis, S Tucker, et al.
European Journal of Drug Metabolism and Pharmacokinetics
|
July 1, 1994
The use of computers in the safety evaluation of drugs and other chemicals
C Ioannides, D F Lewis, D V Parke
Toxicology Letters
|
June 1, 1983
The role of highly purified forms of rat liver cytochrome P-450 in the dimethylation of dimethylnitrosamine and its activation to mutagens
H A Masson, C Ioannides, G G Gibson
Toxicology Letters
|
May 1, 1983
Studies on the possible mutagenicity of beta-adrenergic blocker drugs
L K Okine, C Ioannides, D V Parke
Page
of 25
Search research articles
Search
Showing results (91-100 of 247) with videos related to
Sort By:
Page
of 25
Proceedings of the Royal Society of London. Series B, Biological Sciences
|
February 17, 1970
The tiered retina of Dytiscus: a new type of compound eye
G A Horridge, B Walcott, A C Ioannides
Xenobiotica; the Fate of Foreign Compounds in Biological Systems
|
March 17, 1999
Structural and functional integrity of precision-cut liver slices in xenobiotic metabolism: a comparison of the dynamic organ and multiwell plate culture procedures
E Hashemi, M Dobrota, C Till, et al.
Chemico-Biological Interactions
|
January 1, 1990
Hyperketonaemia markedly modulates the metabolic activation of chemical carcinogens
C R Barnett, P R Flatt, C Ioannides
Mutation Research
|
March 21, 1998
Further evaluation of COMPACT, the molecular orbital approach for the prospective safety evaluation of chemicals
D F Lewis, C Ioannides, D V Parke
Toxicology Letters
|
April 1, 1983
Species variation in the metabolic activation of paracetamol to toxic intermediates: role of cytochromes p-450 and p-448
C Ioannides, C M Steele, D V Parke
Human & Experimental Toxicology
|
November 20, 1998
A combined COMPACT and HazardExpert study of 40 chemicals for which information on mutagenicity and carcinogenicity is known, including the results of human epidemiological studies
D F Lewis, C Ioannides, D V Parke
International Journal of Oncology
|
May 17, 2011
Dissimilar tcr v-Beta frequencies in til from different sites of the same tumor
B Fisk, C Flytzanis, S Tucker, et al.
European Journal of Drug Metabolism and Pharmacokinetics
|
July 1, 1994
The use of computers in the safety evaluation of drugs and other chemicals
C Ioannides, D F Lewis, D V Parke
Toxicology Letters
|
June 1, 1983
The role of highly purified forms of rat liver cytochrome P-450 in the dimethylation of dimethylnitrosamine and its activation to mutagens
H A Masson, C Ioannides, G G Gibson
Toxicology Letters
|
May 1, 1983
Studies on the possible mutagenicity of beta-adrenergic blocker drugs
L K Okine, C Ioannides, D V Parke
Page
of 25